资源类型：
会议/期刊
收录情况：
◇ SCIE
文章类型：
会议摘要
作者：
Li, Y. -S.[1]
*
;
Yang, J. -J.[1]
;
Yu, Q.[2]
;
Bu, Q.[3]
;
Lin, L.[4]
;
Ning, F.[5]
;
Wu, G.[6]
;
Lin, G.[7]
;
Zang, A.[8]
;
Ma, S.[9]
;
Zhou, C.[10]
;
Liu, A.[11]
;
Zhao, Y.
;
Wang, C.[12]
;
Yao, Y.[13]
;
Han, G.[14]
;
Zhao, J.[15]
;
Pan, Y.[1]
;
Sun, H.[1]
;
Zheng, M. -M.[1]
;
Liu, S. -Y. M.[16,17]
;
Yan, H. -H.[1]
;
Tu, H. -Y.[1]
;
Zhou, Q.[1]
;
Lv, J.[18]
;
Wu, Y. -L.[1]
;
机构：
[1]Guangdong Acad Med Sci, Southern Med Univ, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China
广东省人民医院
[2]Guangxi Med Univ, Affiliated Tumor Hosp, Nanning, Peoples R China
[3]Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China
[4]Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou, Peoples R China
[5]Binzhou Med Univ Hosp, Binzhou, Peoples R China
[6]Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Peoples R China
华中科技大学同济医学院附属协和医院
[7]Fujian Canc Hosp, Fuzhou, Peoples R China
[8]Hebei Univ, Sch Clin Med, Affiliated Hosp, Baoding, Peoples R China
河北大学附属医院
[9]Zhejiang Univ, Sch Med, Affiliated Hangzhou Canc Hosp, Hangzhou, Peoples R China
[10]Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[11]Nanchang Univ, Affiliated Hosp 2, Nanchang, Jiangxi, Peoples R China
[12]Southeast Univ, Zhongda Hosp, Nanjing, Peoples R China
[13]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China
[14]Huazhong Univ Sci & Technol, Hubei Canc Hosp, Tongji Med Coll, Wuhan, Peoples R China
[15]Beijing Canc Hosp, Beijing, Peoples R China
[16]Jinan Univ, Inst Hematol, Sch Med, Affiliated Hosp 1, Guangzhou, Peoples R China
[17]Jinan Univ, Minist Educ, Key Lab Regenerat Med, Guangzhou, Peoples R China
[18]Jiangsu Hengrui Pharmaceut Co Ltd, Shanghai, Peoples R China
出处：
JOURNAL OF THORACIC ONCOLOGY.2024,19(10):S399-S400.
ISSN：
1556-0864
关键词：
Brain metastases
Non-small-cell lung
cancer
Camrelizumab
WOS：
WOS:001337925602230
中科院(CAS)分区：
最新[2025]版：
大类
|
1 区
医学
小类
|
1 区
肿瘤学
1 区
呼吸系统
JCR分区：
出版当年[2024]版：
Q1
ONCOLOGY
Q1
RESPIRATORY SYSTEM
最新[2024]版：
Q1
ONCOLOGY
Q1
RESPIRATORY SYSTEM
影响因子：
20.8
最新[2024版]
18.4
最新五年平均
20.8
出版当年[2024版]
18.4
出版当年五年平均
21.1
出版前一年[2023版]
第一作者：
Li, Y. -S.
第一作者机构：
[1]Guangdong Acad Med Sci, Southern Med Univ, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangzhou, Peoples R China
推荐引用方式(GB/T 7714)：
Li Y. -S.,Yang J. -J.,Yu Q.,et al.First Line Camrelizumab for Brain Metastases of NSCLC (CTONG 2003): A Randomized Controlled Trial[J].JOURNAL OF THORACIC ONCOLOGY.2024,19(10):S399-S400.
APA：
Li, Y. -S.,Yang, J. -J.,Yu, Q.,Bu, Q.,Lin, L....&Wu, Y. -L..(2024).First Line Camrelizumab for Brain Metastases of NSCLC (CTONG 2003): A Randomized Controlled Trial.JOURNAL OF THORACIC ONCOLOGY,19,(10)
MLA：
Li, Y. -S.,et al."First Line Camrelizumab for Brain Metastases of NSCLC (CTONG 2003): A Randomized Controlled Trial".JOURNAL OF THORACIC ONCOLOGY 19..10(2024):S399-S400
医学